Sempra
85.01USD
-0.4600 (-0.54%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.08▲ | $1.08 | 1 | 6 |
| Next quarter | $1.42▼ | $1.51 | 1 | 9 |
| Current year | $5.11▼ | $5.11 | 5 | 3 |
| Next year | $5.54▼ | $5.54 | 3 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.06 | $1.16 | +0.10 (+9.6%) |
| 2026-03-31 | $1.51 | $1.51 | -0.00 (-0.3%) |
| 2025-12-31 | $1.17 | $1.28 | +0.11 (+9.2%) |
| 2025-09-30 | $0.91 | $1.11 | +0.20 (+21.7%) |
280 ratings from 24 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $100 $96 | Sep 3, 2026 |
| JP Morgan | Maintained | Overweight | $113 $102 | Sep 2, 2026 |
| Jefferies | Upgraded from Hold | Buy | $101 $97 | Sep 1, 2026 |
| Mizuho | Downgraded from Outperform | Neutral | $104 $84 | Aug 31, 2026 |
| Morgan Stanley | Maintained | Overweight | $108 $104 | Aug 21, 2026 |
| Truist Securities | Maintained | Buy | $107 $100 | Aug 13, 2026 |
| BMO Capital | Maintained | Outperform | $103 $102 | Jul 22, 2026 |
| Barclays | Maintained | Overweight | $105 $103 | Jul 9, 2026 |
| TD Cowen | Initiated | Buy | — | Jul 8, 2026 |
| Truist Securities | Maintained | Buy | $108 $104 | May 18, 2026 |
| BMO Capital | Maintained | Outperform | $105 $103 | May 11, 2026 |
| Morgan Stanley | Maintained | Overweight | $105 $104 | Apr 21, 2026 |
| Truist Securities | Initiated | Buy | $108 | Apr 21, 2026 |
| Barclays | Maintained | Overweight | $95 $105 | Apr 15, 2026 |
| Wells Fargo | Maintained | Overweight | $113 $115 | Mar 23, 2026 |
| JP Morgan | Maintained | Overweight | $98 $106 | Mar 18, 2026 |
| UBS | Maintained | Neutral | $96 $100 | Mar 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $105 $107 | Mar 5, 2026 |
| Argus Research | Upgraded from Hold | Buy | — | Mar 4, 2026 |
| Wells Fargo | Maintained | Overweight | $112 $113 | Feb 27, 2026 |
| Barclays | Maintained | Overweight | $97 $95 | Feb 3, 2026 |
| Morgan Stanley | Maintained | Overweight | $95 $97 | Feb 2, 2026 |
| Barclays | Maintained | Overweight | $98 $97 | Jan 22, 2026 |
| UBS | Maintained | Neutral | $98 $92 | Jan 22, 2026 |
| Wells Fargo | Maintained | Overweight | $115 $112 | Jan 20, 2026 |
66 filings from 18 insiders · 7 buy / 6 sell over 6m
Officers and directors of SRE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WINN CAROLINE ANNOfficer | Sell | 8.0k | $89.85 | $724k | Jun 17, 2026 |
| FERRERO PABLO ADirector | Sell | 2.6k | $89.53 | $233k | May 18, 2026 |
| DAY DIANA LOfficer | Sell | 3.3k | $92.13 | $304k | May 14, 2026 |
| WEAVING ANYADirector | Grant | 1.5k | — | — | May 12, 2026 |
| FERRERO PABLO ADirector | Grant | 1.5k | — | — | May 12, 2026 |
| CONESA ANDRESDirector | Grant | 1.5k | — | — | May 12, 2026 |
| MARK RICHARD JDirector | Grant | 1.5k | — | — | May 12, 2026 |
| BIRD JUSTIN CHRISTOPHEROfficer | Sell | 1.1k | $96.69 | $109k | Apr 1, 2026 |
| WOLD DYAN Z.Officer | Sell | 1.5k | $95.38 | $147k | Mar 16, 2026 |
| KIRK JENNIFER MDirector | Buy | 1.0k | $93.44 | $93k | Mar 12, 2026 |
| MARK RICHARD JDirector | Buy | 2.7k | $93.30 | $251k | Mar 11, 2026 |
| WARNER CYNTHIA JDirector | Buy | 2.5k | $92.95 | $232k | Mar 11, 2026 |
| SEDGWICK KAREN LChief Financial Officer | Sell | 4.9k | $91.36 | $451k | Mar 9, 2026 |
| SEDGWICK KAREN LChief Financial Officer | Grant | 5.2k | — | — | Jan 27, 2026 |
| WINN CAROLINE ANNOfficer | Grant | 4.5k | — | — | Jan 27, 2026 |
| DAY DIANA LOfficer | Grant | 1.8k | — | — | Jan 27, 2026 |
| BIRD JUSTIN CHRISTOPHEROfficer | Grant | 4.9k | — | — | Jan 27, 2026 |
| LARROQUE ALEXANDER LISAOfficer | Grant | 1.7k | — | — | Jan 27, 2026 |
| WOLD DYAN Z.Officer | Grant | 736 | — | — | Jan 27, 2026 |
| MARTIN JEFFREY WChief Executive Officer | Grant | 38.3k | — | — | Jan 27, 2026 |
No analyst notes on SRE yet.
Analyst Ratings
17 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 12 | 4 | 0 | 0 | Buy2.05 |
| 1 mo ago | 3 | 11 | 5 | 0 | 0 | Buy2.11 |
| 2 mo ago | 3 | 12 | 5 | 0 | 0 | Buy2.10 |
| 3 mo ago | 3 | 11 | 5 | 0 | 0 | Buy2.11 |